Claudin 18.2-directed Cytolytic Antibody [EPC]

1525 reported adverse events

Drugs of this class: ZOLBETUXIMAB

These side effects are most commonly reported by patients taking drugs of the Claudin 18.2-directed Cytolytic Antibody [EPC] class:

# Side effect Count
0 NAUSEA 558
1 VOMITING 271
2 DECREASED APPETITE 201
3 ASCITES 138
4 HYPOALBUMINAEMIA 129
5 MALIGNANT NEOPLASM PROGRESSION 117
6 BLOOD ALBUMIN DECREASED 100
7 DIARRHOEA 82
8 OEDEMA PERIPHERAL 67
9 MYELOSUPPRESSION 66
See all common reactions for Claudin 18.2-directed Cytolytic Antibody [EPC]

Drugs of the Claudin 18.2-directed Cytolytic Antibody [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADENOCARCINOMA GASTRIC RECURRENT 2 0.6667
1 METASTASES TO PERINEUM 3 0.2727
2 PROTEIN-LOSING GASTROENTEROPATHY 25 0.0503
3 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 5 0.0338
4 THROMBOPHLEBITIS MIGRANS 8 0.0235
5 HYPOALBUMINAEMIA 129 0.0166
6 GASTRIC STENOSIS 3 0.0164
7 BLOOD ALBUMIN DECREASED 100 0.0126
8 GASTRIC MUCOSA ERYTHEMA 4 0.0121
9 MALIGNANT ASCITES 8 0.0104
See all enriched reactions for Claudin 18.2-directed Cytolytic Antibody [EPC]